An Examination of IC50 and IC50-Shift Experiments in Assessing Time-Dependent Inhibition of CYP3A4, CYP2D6 and CYP2C9 in Human Liver Microsomes

By  

Drug Metabolism Letters, Vol. 2, Iss. 1, 2008-01 ,pp. : 51-59

Bentham Science Publishers

Access to resources Recommend Favorite

Association analysis of CYP2A6 genotypes and haplotypes with 5-fluorouracil formation from tegafur in human liver microsomes

By Wang Huijuan   Bian Ting   Liu Duan   Jin Tianbo   Chen Yong   Lin Aifen   Chen Chao  

Pharmacogenomics, Vol. 12, Iss. 4, 2011-04 ,pp. : 481-492

Future Medicine

Access to resources Recommend Favorite

Inhibitory effects of H-antihistamines on CYP2D6- and CYP2C9-mediated drug metabolic reactions in human liver microsomes

By He Nu   Zhang Wen-Qi   Shockley Dolores   Edeki Timi  

European Journal of Clinical Pharmacology, Vol. 57, Iss. 12, 2002-02 ,pp. : 847-851

Springer Publishing Company

Access to resources Recommend Favorite

An Evaluation of Ondansetron Binding Interactions with Human Cytochrome P450 Enzymes CYP3A4 and CYP2D6

By  

Drug Metabolism Letters, Vol. 4, Iss. 1, 2010-01 ,pp. : 25-30

Bentham Science Publishers

Access to resources Recommend Favorite

Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymes

By Rotzinger S.   Baker G.B.  

European Neuropsychopharmacology, Vol. 12, Iss. 2, 2002-04 ,pp. : 91-100

Elsevier

Access to resources Recommend Favorite